

Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform. Among its major competitors, Nektar Therapeutics is ranked in 1st place for NPS while Alkermes is 2nd, and Genentech is 3rd. Overall, Nektar Therapeutics has a neutral social sentiment, when analyzing social media channels and online mentions.Their current market cap is $113.92M
Nektar Therapeutics's Net Promoter Score (NPS) is a 100 with 100% Promoters, 0% Passives, and 0% Detractors. Net Promoter Score tracks whether Nektar Therapeutics's customers would recommend using the product based on a scale of -100 to 100.
| 100% | Promoters |
|---|---|
| 0% | Passives |
| 0% | Detractors |
| Summary | Date | Score |
|---|---|---|
Feb 2025 100 | Feb 2025 | 100 |
Nektar Therapeutics is ranked first for NPS among its competitors. Alkermes and Genentech come in second and third, with Amgen coming in at #4. Among those competitors, it is the lowest valued company behind Amgen.
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Compared to its competitors, Nektar Therapeutics's NPS is rated right above Alkermes.
| COMPANY | NPS Score | |
|---|---|---|
![]() | Nektar Therapeutics | 100 |
![]() | Alkermes | 47 |
![]() | Genentech | 29 |
![]() | Amgen | 24 |
![]() | Genprex | N/A |
![]() | MEI Pharma | N/A |
Nektar Therapeutics has a 3.3/5 stars for its overall company culture rated by their employees

Nektar Therapeutics scored a 100 for Net Promoter Score and a -63 for Employee Net Promoter Score. NPS gauges how likely a customer of Nektar Therapeutics would recommend the brand to a friend. ENPS measures how likely Nektar Therapeutics employees would recommend working at Nektar Therapeutics to a friend.
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
| 12% | Promoters |
|---|---|
| 13% | Passive |
| 75% | Detractors |